Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Bildung und Mentorschaft fortgeschrittener Praxisanbieter zur Erhöhung der Community-basierten Forschung im NCORP-Netzwerk, Coach-App-Studie (COACH-APP)

1. Oktober 2026 aktualisiert von: Wake Forest University Health Sciences

Aufbau von Kapazitäten innerhalb des NCORP-Netzwerks durch eine Bildungs- und Mentoring-Intervention für fortgeschrittene Praxisanbieter (Coach-App)

This clinical trial evaluates whether a mentorship and education intervention called COACH-APP works to improve advanced practice providers' (APPs) confidence in their ability to participate in clinical research (research self-efficacy). APPs are skilled clinicians who are routinely part of cancer care teams, but who may not routinely be part of the research care team at community oncology sites. The COACH-APP program provides focused education and structured mentorship to assist in meaningful integration to the research care team, which may increase research self-efficacy among APPs and ultimately improve patient care and access to clinical trials.

Studienübersicht

Detaillierte Beschreibung

PRIMARY OBJECTIVE:

I. To compare change in research self-efficacy (RSE) scores from baseline to end of study (12 months post-randomization) between APPs in the COACH-APP intervention compared to the education control.

SECONDARY OBJECTIVES:

I. To compare National Cancer Institute (NCI) Community Oncology Research Program (NCORP) engagement post-study (12-months) for APPs in the COACH-APP intervention compared to the education control.

II. To compare changes from baseline to post-study in APP ratings of research care team integration (Assessment for Collaborative Environments [ACE]-15) between the COACH-APP intervention and education control.

III. To compare practice-level NCORP and National Clinical Trial Network (NCTN) study activity as measured by total number of accruals (patient, non-patient, and organizational) and number of actively recruiting NCORP and NCTN studies over 24 months between practices with APPs receiving the COACH-APP intervention versus those in education control.

IV. Within the COACH-APP intervention group, to measure acceptability, feasibility, and appropriateness of the COACH-APP intervention for APPs and COACH-APP mentors to guide future implementation.

V. Within the COACH-APP intervention group, conduct semi-structured interviews with a sub-set of mentors, APPs, and other key research team members (collaborating oncologists and clinical research professionals) to assess:

  • Va. Perceptions of feasibility, acceptability, and appropriateness of the COACH-APP intervention;
  • Vb. Potential effects of the COACH-APP intervention on the research care team functioning and environment;
  • Vc. Potential effects of the COACH-APP intervention on patient care quality and access to clinical trials;
  • Vd. Practice-level barriers and facilitators of APP engagement in research activities.

Studientyp

Interventionell

Einschreibung (Geschätzt)

97

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

    • Delaware
      • Newark, Delaware, Vereinigte Staaten, 19713
        • Rekrutierung
        • Helen F Graham Cancer Center
        • Hauptermittler:
          • Gregory A Masters
        • Kontakt:
    • Georgia
      • Hinesville, Georgia, Vereinigte Staaten, 31313
        • Rekrutierung
        • Liberty County Cancer Care
        • Kontakt:
        • Hauptermittler:
          • Leonard R Henry
      • Jesup, Georgia, Vereinigte Staaten, 31545
        • Rekrutierung
        • Regional Cancer Care - Jesup
        • Kontakt:
        • Hauptermittler:
          • Leonard R Henry
      • Savannah, Georgia, Vereinigte Staaten, 31405
        • Rekrutierung
        • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
        • Kontakt:
        • Hauptermittler:
          • Leonard R Henry
    • Hawaii
      • Honolulu, Hawaii, Vereinigte Staaten, 96813
        • Rekrutierung
        • Queen's Medical Center
        • Kontakt:
          • Telefonnummer: 808-545-8548
        • Hauptermittler:
          • Christa Braun-Inglis
      • Honolulu, Hawaii, Vereinigte Staaten, 96813
        • Rekrutierung
        • University of Hawaii Cancer Center
        • Kontakt:
          • Telefonnummer: 808-586-2979
        • Hauptermittler:
          • Christa Braun-Inglis
      • ‘Ewa Beach, Hawaii, Vereinigte Staaten, 96706
        • Rekrutierung
        • The Queen's Medical Center - West Oahu
        • Kontakt:
        • Hauptermittler:
          • Christa Braun-Inglis
    • Illinois
      • Bloomington, Illinois, Vereinigte Staaten, 61704
      • Chicago, Illinois, Vereinigte Staaten, 60612
        • Rekrutierung
        • John H Stroger Jr Hospital of Cook County
        • Kontakt:
          • Telefonnummer: 312-864-5204
        • Hauptermittler:
          • Deimante M Tamkus
      • Eureka, Illinois, Vereinigte Staaten, 61530
      • Galesburg, Illinois, Vereinigte Staaten, 61401
      • Macomb, Illinois, Vereinigte Staaten, 61455
      • Mount Vernon, Illinois, Vereinigte Staaten, 62864
        • Rekrutierung
        • SSM Health Good Samaritan
        • Hauptermittler:
          • Jay W Carlson
        • Kontakt:
      • Pekin, Illinois, Vereinigte Staaten, 61554
      • Peoria, Illinois, Vereinigte Staaten, 61615
      • Washington, Illinois, Vereinigte Staaten, 61571
    • Kansas
      • Hays, Kansas, Vereinigte Staaten, 67601
        • Rekrutierung
        • HaysMed
        • Hauptermittler:
          • Jamie Myers
        • Kontakt:
          • Telefonnummer: 785-623-5774
      • Overland Park, Kansas, Vereinigte Staaten, 66210
        • Rekrutierung
        • University of Kansas Cancer Center-Overland Park
        • Kontakt:
        • Hauptermittler:
          • Jamie Myers
      • Westwood, Kansas, Vereinigte Staaten, 66205
        • Rekrutierung
        • University of Kansas Hospital-Westwood Cancer Center
        • Kontakt:
        • Hauptermittler:
          • Jamie Myers
    • Maine
      • Augusta, Maine, Vereinigte Staaten, 04330
        • Rekrutierung
        • Harold Alfond Center for Cancer Care
        • Kontakt:
          • Telefonnummer: 207-626-4855
        • Hauptermittler:
          • Scot C Remick
      • Brunswick, Maine, Vereinigte Staaten, 04011
        • Rekrutierung
        • MaineHealth Cancer Care and IV Therapy - Brunswick
        • Kontakt:
        • Hauptermittler:
          • Scot C Remick
      • Portland, Maine, Vereinigte Staaten, 04102
        • Rekrutierung
        • MaineHealth Maine Medical Center - Portland
        • Kontakt:
        • Hauptermittler:
          • Scot C Remick
      • Scarborough, Maine, Vereinigte Staaten, 04074
        • Rekrutierung
        • MaineHealth Maine Medical Center- Scarborough
        • Kontakt:
        • Hauptermittler:
          • Scot C Remick
      • South Portland, Maine, Vereinigte Staaten, 04106
        • Rekrutierung
        • Maine Health Cancer Care and IV Therapy - South Portland
        • Kontakt:
        • Hauptermittler:
          • Scot C Remick
    • Michigan
      • Chelsea, Michigan, Vereinigte Staaten, 48118
        • Rekrutierung
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
        • Kontakt:
        • Hauptermittler:
          • Rose A Juhasz
      • Reed City, Michigan, Vereinigte Staaten, 49677
        • Rekrutierung
        • Corewell Health Reed City Hospital
        • Kontakt:
        • Hauptermittler:
          • Kathleen Y Butler
      • Ypsilanti, Michigan, Vereinigte Staaten, 48197
        • Rekrutierung
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
        • Kontakt:
        • Hauptermittler:
          • Rose A Juhasz
    • Minnesota
    • Mississippi
      • Columbus, Mississippi, Vereinigte Staaten, 39705
        • Rekrutierung
        • Baptist Memorial Hospital and Cancer Center-Golden Triangle
        • Kontakt:
        • Hauptermittler:
          • Leanna R Fendley
    • Missouri
      • Joplin, Missouri, Vereinigte Staaten, 64804
        • Rekrutierung
        • Mercy Hospital Joplin
        • Hauptermittler:
          • Jay W Carlson
        • Kontakt:
      • Kansas City, Missouri, Vereinigte Staaten, 64154
        • Rekrutierung
        • University of Kansas Cancer Center - North
        • Kontakt:
        • Hauptermittler:
          • Jamie Myers
      • Kansas City, Missouri, Vereinigte Staaten, 64116
        • Rekrutierung
        • University of Kansas Cancer Center - Briarcliff
        • Hauptermittler:
          • Jamie Myers
        • Kontakt:
          • Telefonnummer: 913-588-3671
    • New Mexico
      • Albuquerque, New Mexico, Vereinigte Staaten, 87109
        • Rekrutierung
        • Lovelace Women's Hospital
        • Kontakt:
        • Hauptermittler:
          • Bernard Tawfik
      • Albuquerque, New Mexico, Vereinigte Staaten, 87102
    • North Carolina
      • Winston-Salem, North Carolina, Vereinigte Staaten, 27157
        • Rekrutierung
        • Wake Forest NCORP Research Base
        • Kontakt:
        • Kontakt:
    • Pennsylvania
      • Lewistown, Pennsylvania, Vereinigte Staaten, 17044
        • Rekrutierung
        • Lewistown Hospital
        • Hauptermittler:
          • Christian S Adonizio
        • Kontakt:
    • South Carolina
      • Greenville, South Carolina, Vereinigte Staaten, 29605
        • Rekrutierung
        • Prisma Health Cancer Institute - Faris
        • Kontakt:
        • Hauptermittler:
          • Matgthew F Hudson
      • Greenville, South Carolina, Vereinigte Staaten, 29615
        • Rekrutierung
        • Prisma Health Cancer Institute - Eastside
        • Hauptermittler:
          • Matthew F Hudson
        • Kontakt:
      • Greer, South Carolina, Vereinigte Staaten, 29651
        • Rekrutierung
        • Gibbs Cancer Center-Pelham
        • Kontakt:
        • Hauptermittler:
          • Michael Humeniuk
      • Spartanburg, South Carolina, Vereinigte Staaten, 29303
        • Rekrutierung
        • Spartanburg Medical Center
        • Kontakt:
        • Hauptermittler:
          • Michael Humeniuk
    • South Dakota
      • Sioux Falls, South Dakota, Vereinigte Staaten, 57104
    • Tennessee
      • Memphis, Tennessee, Vereinigte Staaten, 38120
        • Rekrutierung
        • Baptist Memorial Hospital and Cancer Center-Memphis
        • Kontakt:
        • Hauptermittler:
          • Leanna R Fendley
    • Virginia
      • Richmond, Virginia, Vereinigte Staaten, 23298
        • Rekrutierung
        • VCU Massey Comprehensive Cancer Center
        • Kontakt:
        • Hauptermittler:
          • Mary H Hackney
    • Wisconsin
      • Green Bay, Wisconsin, Vereinigte Staaten, 54303
        • Rekrutierung
        • Saint Vincent Hospital Cancer Center at Saint Mary's
        • Hauptermittler:
          • Anthony J Jaslowski
        • Kontakt:

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • APP PRACTICE: Must have one practicing APP who can dedicate approximately 2 hours/month to participate in the intervention and study activities over a 12-month period, supported by their direct supervisor via the APP Support Statement

  • APP PRACTICE: Must attest to research infrastructure that can support APP trial enrollment, as declared on the APP Practice Attestation

  • APP PRACTICE: Must have submitted the APP Practice Attestation within the Study Interest Survey

  • APP PRACTICE: Must have received the required APP practice ID for Oncology Patient Enrollment Network (OPEN) enrollment in the Study Selection Email prior to enrollment

  • APP PRACTICE: Must enroll eligible practice site(s) in OPEN within 14 days of receiving the Study Selection Email.

  • APP: Practicing nurse practitioner (NP) or physician assistant (PA) registered as an active non-physician investigators (NPIVR) within the National Cancer Institute (NCI) Registration and Credential Repository (RCR)

  • APP: Treats oncology patients at practice that is actively recruiting to NCORP and/or NCTN trials

  • APP: Not planning to leave their clinical position within the APP practice (defined as one or more NCORP affiliate or sub-affiliate site[s] where the APP participating in the study sees patients and clinical research activities occur) in the next 12 months at enrollment

  • APP: Willing to participate in a 30-minute recorded phone interview, if selected

  • APP: Completed and submitted the APP Attestation within the Study Interest Survey

  • APP: Completed and submitted an APP Support Statement from their direct supervisor approving participation in this study, within the Study Interest Survey

  • APP: Identify and obtain signed Research Care (RC) Team Acknowledgements from two members (defined below) of their research care team to assist them in this study. The RC team for this study will consist of an oncologist and clinical research professional (i.e., clinical research coordinator, clinical research associate clinical research nurse, etc.) that the APP collaborated with over the past 6 months or could collaborate with in the future to enroll patients on NCORP and/or NCTN trials

  • APP: Must have received the required APP practice ID for OPEN enrollment in the Study Selection Email

  • APP: Must enroll consented APPs in OPEN within 14 days of receiving the Study Selection Email

  • MENTOR: Must be a practicing APP chosen by the WF-2403 COACH-APP Study MPIs

  • MENTOR: Must have the following criteria:

    • Clinical practice experience in a practice that enrolls to NCORP and/or NCTN trials.
    • Participation in a leadership role within NCTN or NCORP (i.e., serving on a Research Base committee, working group, taskforce or as a site PI)
    • Willing to complete COACH-APP mentor training.
    • Willing to complete a 30-minute recorded phone interview about their experience with the COACH-APP intervention
  • RESEARCH CARE TEAM INTERVIEW: Must be an identified member of the Research Care Team for an APP assigned to the COACH-APP intervention arm. The Research Care Team will be reviewed by the APP in the 12 month survey for any changes

  • RESEARCH CARE TEAM INTERVIEW: Willing to participate in a recorded phone interview (approximately 30 minutes) to assess their perceptions of the COACH-APP intervention, including feasibility, acceptability, and impact

Exclusion Criteria:

  • APP PRACTICE: APP practice has an APP serving as a COACH-APP intervention mentor
  • APP PRACTICE: Another APP at the same APP practice is already enrolled in this study (i.e., only 1 APP is allowed per APP practice)
  • APP PRACTICE: Affiliate/sub-affiliate site(s) within this APP practice are already enrolled or are intended to be enrolled in this study under another APP practice
  • APP: Has already completed the SWOG APP workshop
  • APP: Served as a site principal investigator (PI) for an NCORP or NCTN study at any time
  • APP: Participated as a presenter for the SWOG APP workshop
  • APP: Participated on the planning committee for The Advanced Practice Provider Clinical Trials Research Manual
  • APP: Participated on the planning committee for the SWOG APP workshop
  • APP: Past or current member of SWOG APP Task Force Committee
  • APP: Past or current member of Eastern Cooperative Oncology Group- American College of Radiology Imaging Network (ECOG-ACRIN) APP Committee
  • MENTOR: Must not work at NC002-Wake Forest University Health Sciences or its affiliate/subaffiliate sites

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Sonstiges
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Arm I (COACH-APP)

APPs complete the SWOG APP Clinical Research Workshop, consisting of 6 modules, over 2 hours and receive The Advanced Practice Provider Clinical Trials Research Manual. APPs also complete 5 mentoring sessions, over 15-60 minutes each, over 12 months.

Ancillary studies

Ancillary studies

Receive access to SWOG APP Clinical Research workshop. Receive The Advanced Practice Provider Clinical Trials Research Manual

Complete mentorship intervention

Aktiver Komparator: Arm II (education control)

APPs receive access to the SWOG APP Clinical Research Workshop and The Advanced Practice Provider Clinical Trials Research Manual for 12 months.

Ancillary studies

Receive access to SWOG APP Clinical Research workshop. Receive The Advanced Practice Provider Clinical Trials Research Manual

Sonstiges: Mentors

The seven COACH-APP Mentors who provide the mentorship in the COACH-APP arm will also be enrolled as participants in the study.

Ancillary studies

Ancillary studies

Sonstiges: Research Care Team Members

20 Research Care Team Members will also be enrolled in the study to participate in qualitative interviews to assess their perceptions of the COACH-APP intervention.

Ancillary studies

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Research self-efficacy (RSE)
Zeitfenster: From baseline to 12 months post-randomization

RSE score is calculated as sum of the 22-items measured on a 5-point Likert scale. Will be compared between the COACH-APP intervention and education control arms using a two-sample t-test.

From baseline to 12 months post-randomization

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
National Cancer Institute Community Oncology Research Program (NCORP) engagement
Zeitfenster: At 12 months post randomization

Measured by the sum of 8-items measured on a 5-point Likert scale. Will be compared between the COACH-APP intervention and education control arms using linear regression.

At 12 months post randomization
Change in research care team integration
Zeitfenster: From baseline to 12 months post randomization

Measured by the Assessment for Collaborative Environments (ACE)-15. Will follow the same analysis plan as for the primary outcome.

From baseline to 12 months post randomization
Practice-level NCORP and National Clinical Trials Network (NCTN) study activity
Zeitfenster: Up to 24 months

Measured by total number of accruals (patient, non-patient, and organizational) and number of actively recruiting NCORP and NCTN studies. Will be compared between the COACH-APP intervention and education control arms using linear regression.

Up to 24 months
Acceptability of COACH-APP intervention (COACH-APP arm only)
Zeitfenster: At 12 months

As measured by Acceptability of Intervention Measure (AIM). Will be summarized for the APPs in the COACH-APP intervention arm using mean and standard deviation and by capturing the percent who agree or strongly agree with the items.

At 12 months
Feasibility of COACH-APP intervention (COACH-APP arm only)
Zeitfenster: At 12 months

As measured by Feasibility of Intervention Measure (FIM). Will be summarized for the APPs in the COACH-APP intervention arm using mean and standard deviation and by capturing the percent who agree or strongly agree with the items.

At 12 months
Appropriateness of COACH-APP intervention (COACH-APP arm only)
Zeitfenster: At 12 months

As measured by Intervention Appropriateness Measure (IAM). Will be summarized for the APPs in the COACH-APP intervention arm using mean and standard deviation and by capturing the percent who agree or strongly agree with the items.

At 12 months
Perceptions of feasibility of the COACH-APP intervention
Zeitfenster: Day 1 (At time of interview)

Measured via qualitative interview. Thematic analysis of the qualitative data will be used to summarize key themes from the APP, Mentor and RC Team semi-structured interview recordings and transcripts.

Day 1 (At time of interview)
Perceptions of acceptability of the COACH-APP intervention
Zeitfenster: Day 1 (At time of interview)

Measured via qualitative interview. Thematic analysis of the qualitative data will be used to summarize key themes from the APP, Mentor and RC Team semi-structured interview recordings and transcripts.

Day 1 (At time of interview)
Perceptions of appropriateness of the COACH-APP intervention
Zeitfenster: Day 1 (At time of interview)

Measured via qualitative interview. Thematic analysis of the qualitative data will be used to summarize key themes from the APP, Mentor and RC Team semi-structured interview recordings and transcripts.

Day 1 (At time of interview)
Potential effects of the COACH-APP intervention on the research care team functioning and environment
Zeitfenster: Day 1 (At time of interview)

Measured via qualitative interviews. Thematic analysis of the qualitative data will be used to summarize key themes from the APP, Mentor and RC Team semi-structured interview recordings and transcripts.

Day 1 (At time of interview)
Potential effects of the COACH-APP intervention on patient care quality and access to clinical trials
Zeitfenster: Day 1 (At time of interview)

Measured via qualitative interviews. Thematic analysis of the qualitative data will be used to summarize key themes from the APP, Mentor and RC Team semi-structured interview recordings and transcripts.

Day 1 (At time of interview)
Practice-level barriers and facilitators of APP engagement in research activities
Zeitfenster: Day 1 (At time of interview)

Measured via qualitative interviews. Thematic analysis of the qualitative data will be used to summarize key themes from the APP, Mentor and RC Team semi-structured interview recordings and transcripts.

Day 1 (At time of interview)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Studienstuhl: Glenn Lesser, MD, Wake Forest University Health Sciences

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

5. September 2025

Primärer Abschluss (Geschätzt)

30. Juni 2028

Studienabschluss (Geschätzt)

30. Juni 2028

Studienanmeldedaten

Zuerst eingereicht

24. März 2025

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

31. März 2025

Zuerst gepostet (Tatsächlich)

1. April 2025

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

5. Oktober 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

1. Oktober 2026

Zuletzt verifiziert

1. Oktober 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

Wake Forest NCORP Research Base is committed to following the NIH Statement on Sharing Research Data (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html). As of July 2018, the WF NCORP RB signed an agreement with NCI to contribute de-identified data and data dictionaries from clinical trials conducted through our RB to the NCI NCTN/NCORP data archive within 6 months of primary and non-primary publications of phase II/III and phase III trials to https://nctn-data-archive.nci.nih.gov/. This will become the primary means for sharing raw data, and we will adhere to the guidelines spelled out in the NCTN/NCORP Data Archive Usage Guide. De-identified data from studies not covered by the agreement (e.g., phase II and observational studies) will be made available upon request. All data files will be de-identified. De-identification procedures will meet the HIPAA criteria as detailed in the Code of Federal Regulations, Part 45, Section 164.514.

IPD-Sharing-Zeitrahmen

6 months after publication for a 2 year duration

IPD-Sharing-Zugriffskriterien

upon request to NCORP@wakehealth.edu

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren